Reported a net loss of $13.86 million for the quarter ended March 31, 2026, compared to $2.12 million in the prior-year period. Completed the acquisition of Greenland Mines Corp. on March 4, 2026, for approximately $48.4 million in preferred stock and cash. Cash and cash equivalents stood at $10.0 million as of March 31, 2026. Operating expenses rose to $9.51 million, driven by increased professional fees and general administrative costs post-merger. Recognized a $2.05 million impairment charge on legacy biotech intangible assets. The company now operates in two segments: Biotechnology and Mining.